Cleared Traditional

SI-TECHNOLOGY® SI-DESIS® X™ Sacroiliac Joint Fusion System (K241813) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241813 · Si-Technology, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
53d
Days
Class 2
Risk

K241813 is an FDA 510(k) clearance for the SI-TECHNOLOGY® SI-DESIS® X™ Sacroiliac Joint Fusion System. Classified as Sacroiliac Joint Fixation (product code OUR), Class II - Special Controls.

Submitted by Si-Technology, LLC (Fort Collins, US). The FDA issued a Cleared decision on August 13, 2024 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Si-Technology, LLC devices

Submission Details

510(k) Number K241813 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2024
Decision Date August 13, 2024
Days to Decision 53 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 122d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OUR Sacroiliac Joint Fixation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
Definition Sacroiliac Joint Fusion
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Secure BioMed Evaluations
Justin Gracyalny

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OUR Sacroiliac Joint Fixation

All 99
Devices cleared under the same product code (OUR) and FDA review panel - the closest regulatory comparables to K241813.
TiLink-P Joint Fusion System
K242414 · SurGenTec, LLC · Nov 2024
TiLink-P SI Joint Fusion System
K242141 · SurGenTec, LLC · Aug 2024
iFuse TORQ TNT™ Implant System
K241504 · SI-BONE, Inc. · Aug 2024
ARx® SAI Implant System
K241464 · Life Spine, Inc. · Jul 2024
iFuse TORQ® Implant System
K241574 · SI-BONE, Inc. · Jul 2024
Eminent Spine SI Screw System
K240505 · Eminent Spine, LLC · Jun 2024